• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nitric oxide inhibition of coxsackievirus replication in vitro.一氧化氮对柯萨奇病毒体外复制的抑制作用
J Clin Invest. 1997 Oct 1;100(7):1760-7. doi: 10.1172/JCI119702.
2
Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.一氧化氮供体在体外可抑制柯萨奇病毒B3蛋白酶2A和3C、细胞中的病毒产生以及病毒感染小鼠的心肌炎症状。
Med Microbiol Immunol. 2004 May;193(2-3):91-100. doi: 10.1007/s00430-003-0198-6. Epub 2003 Sep 26.
3
Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway.吡咯烷二硫代氨基甲酸盐通过抑制泛素-蛋白酶体途径降低柯萨奇病毒B3的复制。
J Virol. 2005 Jul;79(13):8014-23. doi: 10.1128/JVI.79.13.8014-8023.2005.
4
Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.锌指抗病毒蛋白抑制柯萨奇 B3 病毒复制并保护免受病毒性心肌炎。
Antiviral Res. 2015 Nov;123:50-61. doi: 10.1016/j.antiviral.2015.09.001. Epub 2015 Sep 2.
5
Baicalin Inhibits Coxsackievirus B3 Replication by Reducing Cellular Lipid Synthesis.黄芩苷通过降低细胞脂质合成抑制柯萨奇病毒 B3 复制。
Am J Chin Med. 2020;48(1):143-160. doi: 10.1142/S0192415X20500081. Epub 2020 Jan 6.
6
Nitric oxide radical suppresses replication of wild-type dengue 2 viruses in vitro.
J Med Virol. 2005 Sep;77(1):89-95. doi: 10.1002/jmv.20418.
7
Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy.一氧化氮通过S-亚硝基化抑制柯萨奇病毒蛋白酶2A引起的肌营养不良蛋白蛋白水解:一种针对肠道病毒心肌病的保护机制。
Circulation. 2000 Oct 31;102(18):2276-81. doi: 10.1161/01.cir.102.18.2276.
8
Specific inhibition of coxsackievirus B3 translation and replication by phosphorothioate antisense oligodeoxynucleotides.硫代磷酸酯反义寡脱氧核苷酸对柯萨奇病毒B3翻译和复制的特异性抑制作用
Antimicrob Agents Chemother. 2001 Apr;45(4):1043-52. doi: 10.1128/AAC.45.4.1043-1052.2001.
9
Study on the inhibitory effect of antisense phosphorothioate oligodeoxynucleotide on coxsackie virus B replication in vitro.硫代磷酸反义寡脱氧核苷酸对柯萨奇病毒B体外复制抑制作用的研究
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2000 Sep;14(3):253-6.
10
Development of potent inhibitors of the coxsackievirus 3C protease.柯萨奇病毒3C蛋白酶强效抑制剂的研发
Biochem Biophys Res Commun. 2007 Jun 22;358(1):7-11. doi: 10.1016/j.bbrc.2007.03.208. Epub 2007 Apr 20.

引用本文的文献

1
Identification of picornavirus proteins that inhibit de novo nucleotide synthesis during infection.鉴定在感染过程中抑制从头核苷酸合成的小核糖核酸病毒蛋白。
PLoS Pathog. 2025 Jul 3;21(7):e1013293. doi: 10.1371/journal.ppat.1013293. eCollection 2025 Jul.
2
Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms.一氧化氮与病毒感染:抗病毒疗法及平台的最新进展
Appl Mater Today. 2021 Mar;22:100887. doi: 10.1016/j.apmt.2020.100887. Epub 2020 Dec 5.
3
The Potential Role of Nitric Oxide as a Therapeutic Agent against SARS-CoV-2 Infection.一氧化氮作为治疗 SARS-CoV-2 感染的潜在药物的作用。
Int J Mol Sci. 2023 Dec 5;24(24):17162. doi: 10.3390/ijms242417162.
4
The Renin-Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes.肾素-血管紧张素-醛固酮系统、一氧化氮和硫化氢在高血压和 COVID-19 的交叉点:种族差异和结果。
Int J Mol Sci. 2022 Nov 11;23(22):13895. doi: 10.3390/ijms232213895.
5
Utility of NO and HS donating platforms in managing COVID-19: Rationale and promise.NO 和 HS 供体平台在管理 COVID-19 中的效用:原理和前景。
Nitric Oxide. 2022 Nov 1;128:72-102. doi: 10.1016/j.niox.2022.08.003. Epub 2022 Aug 24.
6
Mechanisms and Therapeutic Strategies of Viral Myocarditis Targeting Autophagy.靶向自噬的病毒性心肌炎的机制与治疗策略
Front Pharmacol. 2022 Apr 11;13:843103. doi: 10.3389/fphar.2022.843103. eCollection 2022.
7
NO in Viral Infections: Role and Development of Antiviral Therapies.病毒感染中的一氧化氮:抗病毒治疗的作用和发展。
Molecules. 2022 Apr 5;27(7):2337. doi: 10.3390/molecules27072337.
8
Nitric oxide boosters as defensive agents against COVID-19 infection: an opinion.一氧化氮增强剂作为预防 COVID-19 感染的防御剂:一种观点。
J Biomol Struct Dyn. 2022 Jun;40(9):4285-4291. doi: 10.1080/07391102.2020.1852969. Epub 2020 Nov 30.
9
Nitric oxide synthases, S-nitrosylation and cardiovascular health: from molecular mechanisms to therapeutic opportunities (review).一氧化氮合酶、S-亚硝基化与心血管健康:从分子机制到治疗机遇(综述)
Mol Med Rep. 2015 Mar;11(3):1555-65. doi: 10.3892/mmr.2014.2968. Epub 2014 Nov 18.
10
Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.针对基质金属蛋白酶活性和表达治疗病毒性心肌炎。
J Cardiovasc Transl Res. 2014 Mar;7(2):212-25. doi: 10.1007/s12265-013-9528-2. Epub 2014 Jan 1.

本文引用的文献

1
The antiviral role of nitric oxide.一氧化氮的抗病毒作用。
Res Immunol. 1995 Nov-Dec;146(9):693-7. doi: 10.1016/0923-2494(96)84920-0.
2
NO inhibitions: antimicrobial properties of nitric oxide.无抑制作用:一氧化氮的抗菌特性
Clin Infect Dis. 1995 Oct;21 Suppl 2:S162-5. doi: 10.1093/clinids/21.supplement_2.s162.
3
Hemodynamic effects of L- and D-S-nitrosocysteine in the rat. Stereoselective S-nitrosothiol recognition sites.L-和D-S-亚硝基半胱氨酸对大鼠的血流动力学影响。立体选择性亚硝基硫醇识别位点。
Circ Res. 1996 Aug;79(2):256-62. doi: 10.1161/01.res.79.2.256.
4
Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease.柯萨奇病毒B型的心脏毒力与炎症性心肌病的遗传学
Trends Microbiol. 1996 May;4(5):175-9. doi: 10.1016/0966-842x(96)10026-3.
5
Coxsackievirus B3 clinical isolates and murine myocarditis.柯萨奇病毒B3临床分离株与小鼠心肌炎
Virus Res. 1996 Mar;41(1):89-99. doi: 10.1016/0168-1702(95)01250-8.
6
Coxsackievirus-induced chronic myocarditis in murine models.柯萨奇病毒诱导的小鼠模型慢性心肌炎
Eur Heart J. 1995 Dec;16 Suppl O:56-8. doi: 10.1093/eurheartj/16.suppl_o.56.
7
Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis.一氧化氮合成的抑制增加了辛德毕斯病毒脑炎的死亡率。
J Virol. 1996 Jun;70(6):3972-7. doi: 10.1128/JVI.70.6.3972-3977.1996.
8
Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals.流感病毒诱导的肺炎的发病机制:一氧化氮和氧自由基的参与
Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2448-53. doi: 10.1073/pnas.93.6.2448.
9
Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants.内部核糖体进入位点替换消除了属间脊髓灰质炎病毒重组体的神经毒力。
Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2370-5. doi: 10.1073/pnas.93.6.2370.
10
Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment.甘油醛-3-磷酸脱氢酶的翻译后修饰:S-亚硝基化及随后的NADH附着
J Biol Chem. 1996 Feb 23;271(8):4209-14. doi: 10.1074/jbc.271.8.4209.

一氧化氮对柯萨奇病毒体外复制的抑制作用

Nitric oxide inhibition of coxsackievirus replication in vitro.

作者信息

Zaragoza C, Ocampo C J, Saura M, McMillan A, Lowenstein C J

机构信息

Division of Cardiology, Department of Medicine, School of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

出版信息

J Clin Invest. 1997 Oct 1;100(7):1760-7. doi: 10.1172/JCI119702.

DOI:10.1172/JCI119702
PMID:9312175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC508360/
Abstract

Nitric oxide is a radical molecule with antibacterial, -parasitic, and -viral properties. We investigated the mechanism of NO inhibition of Coxsackievirus B3 (CVB3) replication in vitro by determining the effect of NO upon a single replicative cycle of CVB3 grown in HeLa cells. Transfection of inducible NO synthase cDNA into HeLa cells reduces the number of viral particles produced during a single cycle of growth. Similarly, a noncytotoxic concentration of the NO donor S-nitroso-amino-penicillamine reduces the number of viral particles in a dose-dependent manner. To explore the mechanisms by which NO exerts its antiviral effect, we assayed the attachment, replication, and translation steps of the CVB3 life cycle. NO does not affect the attachment of CVB3 to HeLa cells. However, NO inhibits CVB3 RNA synthesis, as shown by a [3H]uridine incorporation assay, reverse transcription-PCR, and Northern analysis. In addition, NO inhibits CVB3 protein synthesis, as shown by [35S]methionine protein labeling and Western blot analysis of infected cells. Thus, NO inhibits CVB3 replication in part by inhibiting viral RNA synthesis by an unknown mechanism.

摘要

一氧化氮是一种具有抗菌、抗寄生虫和抗病毒特性的自由基分子。我们通过测定一氧化氮对在HeLa细胞中生长的柯萨奇病毒B3(CVB3)单个复制周期的影响,研究了一氧化氮在体外抑制CVB3复制的机制。将诱导型一氧化氮合酶cDNA转染到HeLa细胞中可减少单个生长周期内产生的病毒颗粒数量。同样,一氧化氮供体S-亚硝基-氨基青霉胺的非细胞毒性浓度以剂量依赖方式减少病毒颗粒数量。为了探究一氧化氮发挥其抗病毒作用的机制,我们检测了CVB3生命周期的附着、复制和翻译步骤。一氧化氮不影响CVB3与HeLa细胞的附着。然而,如[3H]尿苷掺入试验、逆转录-PCR和Northern分析所示,一氧化氮抑制CVB3 RNA合成。此外,如[35S]甲硫氨酸蛋白标记和对感染细胞的Western印迹分析所示,一氧化氮抑制CVB3蛋白合成。因此,一氧化氮部分通过未知机制抑制病毒RNA合成来抑制CVB3复制。